Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Junichi Asano
Observed names:
J. Asano,
JUN‐ICHI ASANO,
Jun-ichi Asano,
Jun‐Ichi Asano,
Jun‐ichi Asano
Institutions:
Institute of Science Tokyo,
Pharmaceuticals and Medical Devices Agency
Observed institutions:
Tokyo Medical and Dental University,
Hamamatsu University,
Tokyo University of Science,
Hamamatsu University School of Medicine,
Gifu University,
Institute of Science Tokyo,
Tottori University,
Pharmaceuticals and Medical Devices Agency
show all 8
ORCID:
0000-0002-0803-8738
Observed ORCID:
0000-0002-0803-8738
OpenAlex ID:
A5061935287
Master protocol trials in oncology: Review and new trial designs
2018
·
Akihiro Hirakawa
, Junichi Asano
, et al.
·
Contemporary Clinical Trials Communications
·
131
Regulatory Issues: PMDA – Review of Sakigake Designation Products: Oncolytic Virus Therapy with Delytact Injection (Teserpaturev) for Malignant Glioma
2023
·
Yoshiaki Maruyama
, Akira Sakurai
, et al.
·
The Oncologist
·
50
PDF
Epidemiology of Progressive Muscular Dystrophy in Okinawa, Japan
1991
·
Masanori Nakagawa
, Keiichi Nakahara
, et al.
·
Neuroepidemiology
·
47
Assessing the prediction accuracy of cure in the Cox proportional hazards cure model: an application to breast cancer data
2014
·
Junichi Asano
, Akihiro Hirakawa
, et al.
·
Pharmaceutical Statistics
·
26
Effects of erucic acid therapy on Japanese patients with X-linked adrenoleukodystrophy
1994
·
Jun-ichi Asano
, Yasuyuki Suzuki
, et al.
·
Brain and Development
·
26
Insights into the clinical development of regenerative medical products through a comparison of three cell-based products recently approved for limbal stem cell deficiency
2023
·
Naohiko Aketa
, Masaki Kasai
, et al.
·
The Ocular Surface
·
21
Balanced complex rearrangement involving chromosomes 8, 9, and 12 in a normal mother, derivative chromosome 9 with recombinant chromosome 12 in her daughter with minor anomalies
1993
·
Mitsuo Masuno
, Jun‐Ichi Asano
, et al.
·
American Journal of Medical Genetics
·
19
Regulatory advancements in Japan's conditional and time-limited approval scheme for regenerative medical products: the first guidance on the approval scheme and the second review for full approval of the first conditional and time-limited approved cellular product, HeartSheet
2025
·
Shinichi Noda
, Yoko Kobayashi
, et al.
·
Cytotherapy
·
18
PDF
Assessing the prediction accuracy of a cure model for censored survival data with long-term survivors: Application to breast cancer data
2017
·
Junichi Asano
, Akihiro Hirakawa
·
Journal of Biopharmaceutical Statistics
·
18
A Bayesian basket trial design accounting for uncertainties of homogeneity and heterogeneity of treatment effect among subpopulations
2020
·
Junichi Asano
, Akihiro Hirakawa
·
Pharmaceutical Statistics
·
17
PMDA Perspective on Use of Real‐World Data and Real‐World Evidence as an External Control: Recent Examples and Considerations
2025
·
Junichi Asano
, Hiromi Sugano
, et al.
·
Clinical Pharmacology & Therapeutics
·
15
PDF
Interstitial deletion of 17pl 1.2 with brain abnormalities
1992
·
Mitsuo Masuno
, Jun‐ichi Asano
, et al.
·
Clinical Genetics
·
12
Exposure of Drugs for Hypertension, Diabetes, and Autoimmune Disease During Pregnancy and Perinatal Outcomes: An Investigation of the Regulator in Japan
2015
·
Ryosuke Sato
, Mutsuhiro Ikuma
, et al.
·
Medicine
·
11
Chediak‐Higashi syndrome with cerebellar cortical atrophy detected by MRI
1994
·
Naomi Kondo
, Nobuyuki Shimozawa
, et al.
·
Clinical Genetics
·
11
Gene deletions in Japanese patients with Duchenne and Becker muscular dystrophies: deletion study and carrier detection
1991
·
Jun‐Ichi Asano
, Shunji Tomatsu
, et al.
·
Clinical Genetics
·
11
A Stepwise Variable Selection for a Cox Proportional Hazards Cure Model with Application to Breast Cancer Data
2013
·
Junichi Asano
, Akihiro Hirakawa
, et al.
·
Japanese Journal of Biometrics
·
9
PDF
Improvement of clinical and MM findings in a boy with adrenoleukodystrophy by dietary erucic acid therapy
1992
·
Keiko Maeda
, Yasuyuki Suzuki
, et al.
·
Brain and Development
·
9
Clinical characteristics of COVID-19 patients with underlying rheumatic diseases in Japan: data from a multicenter observational study using the COVID-19 Global Rheumatology Alliance physician-reported registry
2022
·
Mari Kihara
, Takahiko Sugihara
, et al.
·
Clinical Rheumatology
·
8
PDF
Insulin‐dependent diabetes developed in a young man with Bloom's syndrome
1991
·
Naomi Kondo
, Junichi Asano
, et al.
·
Clinical Genetics
·
8
Use of Cox’s Cure Model to Establish Clinical Determinants of Long-Term Disease-Free Survival in Neoadjuvant-Chemotherapy-Treated Breast Cancer Patients without Pathologic Complete Response
2013
·
Junichi Asano
, Akihiro Hirakawa
, et al.
·
International Journal of Breast Cancer
·
7
Gene deletions in Japanese patients with Duchenne and Becker muscular dystrophy
1990
·
Jun-ichi Asano
, Shunji Tomatsu
, et al.
·
The Japanese Journal of Human Genetics
·
7
Assessment of the impact of Japanese‐specific long‐term safety data on new drug approval
2021
·
Shinobu Uzu
, Shohko Sekine
, et al.
·
Clinical and Translational Science
·
3
PDF
Cancer Clinical Trials Based on Master Protocol
2019
·
Akihiro Hirakawa
, Junichi Asano
, et al.
·
Japanese Journal of Biometrics
·
3
Practical basket design for binary outcomes with control of family-wise error rate
2023
·
Junichi Asano
, Hiroyuki Sato
, et al.
·
BMC Medical Research Methodology
·
2
PDF
Experiences from Japan: conditional and time-limited approval – an early approval scheme for regenerative medical products
2019
·
Yoshiaki Maruyama
, Masaki Kasai
, et al.
·
Cell and Gene Therapy Insights
·
2
Show more works
View as search
Works count:
32
Citation count:
496
H-index:
12
I10-index:
15
Year
Topic
Type